Browse by Track

(100) Incorporating enzymatic activity into in vitro analysis of biotransformable drugs

(101) Microstructural Analysis of In Situ Formed Depots for Universal In Vitro Assessment

(102) Local Inflammation Response of Salbutamol Formulations on ex-vivo Mouse Skin

(103) Machine learning driven web-based app platform for the designing of monoamine oxidase B inhibitors

(104) Scaling Rules for Designing Intra-vaginal Rings and PK Studies in Animals vs. Humans

(105) Mathematical Modeling Explains the Strain-Dependence of Monoclonal Antibody Pharmacokinetics in Mice

(106) 3D In Vitro Models of Osteosarcoma: A Novel Hydrogel-Scaffold System for Therapeutic Research

(107) Long-Acting Injectable Dose Prediction: Where Are We Really?

(108) Novel Integrated PBPK-IVIVC Framework for Predicting Human PK of Sustained-Release Formulations

(109) Target-mediated drug disposition modeling of nonlinear pharmacokinetics in GLP-1 receptor agonists

(110) Unmanned Aerial Vehicle-Mediated Drug Delivery for First Aid

(112) TuNa-AI: A Hybrid Kernel Machine to Design Tunable Nanoparticles for Drug Delivery

(113) Physiologically Based Pharmacokinetic Modeling and IVIVC for Long-Acting Injectable Suspensions

(114) A Method to Quantify Protein Binding Kinetics and Supersaturated Solutions Precipitation Kinetics

(115) Membrane dynamics modulate the functional activity of biomimetic nanoparticles

(116) Exploiting Metabolite-Presenting Molecules for Targeted Therapies

(117) Efficient and controlled drug release from PEDOT synthesised via surface-tethered dopant templating

(118) Biomimetic RBC-Liposomes: Impact of Membrane Properties on Protein Corona and Stability

(119) Unveiling the Role of Lipid Composition on Stability and Fusion of Biomimetic Liposomes

(120) Cluster differentiation-modified liposomes for lung targeted anti-inflammatory therapy

(121) Synthesis of exosome-mimicking exosomal nanoparticles using a microfluidic chip

(122) Bioinspired lipoprotein-mimetic nanocarriers: Tackling drug solubility and permeability challenges

(123) Endoplasmic reticulum stress-based approach for reprogramming tumor-derived exosome

(124) Microfluidic Fabrication of Alginate-PEGDGE Hydrogel Microspheres for Drug Delivery and Cell Therapy

(125) Macrophage-Mediated Delivery of Focused Ultrasound-Activated Nanocarriers for Triggered Drug Release

(126) Novel Intravenous Anticoagulant: Development and Testing for Safe, Effective Thrombosis Prevention

(127) Interactions of biomimetic liposomes with enterocytes explored by 3D Raman imaging

(128) Development of a microfluidic chip for efficient lipid formulation discovery of lipid nanoparticles

(129) Engineering Metal-Organic Framework-biopolymer-based Hydrogels for Controlled Therapeutic Delivery

(130) Development of TransMIT, nanocapsules for mitochondria-mediated cell function modulation

(131) Development of a solid-phase synthetic approach for triazine-based lipids

(132) Multimodal evaluation of a porous HA/β-TCP scaffold for bone repair and localized therapy in rats.

(133) Anticancer activity of extended release loperamide from styrene-isoprene-styrene polymer in vitro

(134) Cryoshocked T Lymphocytes (CSTLs) for Enhanced Delivery of Chemotherapeutics to the Lymph Node

(135) Responsive Silk Protein Plastics for Controlled Drug Release

(136) Biomimetic Multilayered Lipid Nanovesicle Vaccine Targeting Staphylococcus aureus α-Hemolysin

(137) Dendritic particles with nanostructured tendrils for adhesion and drug release to bladder cancers

(138) Kidnapper SA-Biosomes for alveolar macrophages targeting for managing pulmonary inflammation.

(139) Rheology-driven development of bioinks for advanced 3D-bioprinting in drug discovery

(140) Mesenchymal stem cells as gene delivering vehicles for activating prodrug around tumor cells

(141) Ultrasonic stimulation in a 3D HA hydrogel accelerates cellular reprogramming for iPS generation

(142) Erythrocyte membrane biomimetic nanoparticles for Dapagliflozin delivery in the fibrotic heart

(143) Synthesis and its HTS of Antibody conjugated quantum dots functionalized Palbociclib nanocarriers

(145) Film Formation from Alpha-Glucan Polysaccharide Nanoparticles For Controlled Release ID: 2003914

(147) GPNMB as an Orthobiologic for Bone Regeneration and Spinal Fusion for an Osteoporotic Rat Model

(148) Green formulations of benzalkonium chloride with enhanced antibacterial properties.

(149) Manufacturing near monodispersed solvent free complex coacervation microcapsules at industrial scale

(150) Sustained Release Implant Delivery of BDNF Upregulating Oligonucleotide in Parkinson’s Disease

(151) Microglia-targeting nanocarriers reduce hypothalamic inflammation in cancer-related cachexia

(152) Harnessing cannabidiol and lipid nanocapsules to modulate P-glycoprotein in glioma

(153) Two to tango: chemotherapy “speed-dating” for cannabidiol in lipid nanocapsules against glioblastoma

(154) Nasal-to-brain Approach: lipid-coated Clozapine Albumin Nanoparticles for Treatment of Schizophrenia

(155) In-Vivo Study on Nose-to-Brain Delivery of Liposomal siRNA/Drug Combination for Alzheimer’s Disease

(156) A new technology for photo-controlled release of bioactive molecules in the brain.

(157) Microfluidic formulations of Non Ionic Surfactant Vesicles

(158) Lipid Polymer Hybrid Nanoparticles for pulmonary mRNA delivery

(159) Exploring Substrate Stiffness and YAP/TAZ Pathways in Non-Viral Gene Delivery Applications

(160) Targeted Lipid Nanoparticles for Delivery of Gene Editing Technology to the Pulmonary Vasculature

(161) A dive into optimization of novel ionizable lipid nanoparticles for enhanced siRNA delivery

(162) Branched Copolymer Nanogels Synthesized by RAFT Polymerization for Gene Delivery Vehicles

(163) Nanoparticle-mediated E-selectin siRNA Delivery Reduces Inflammation in MHV-3 Infected Mice

(164) mRNA-Lipid Nanoparticle Formulations for Targeted Drug Delivery as Cancer Vaccines

(165) Lung editing via inhalation of base editors delivered by amino acid-derived lipid nanoparticles

(166) Iterative High-throughput Screening Identifies Nanoparticles with Improved Delivery Efficiency

(167) Acid-degradable Dextran as a Carrier for Melanoma Gene Therapy

(168) Advanced lentiviral vector engineering with polymer surface modification for CAR-T cell therapy

(169) Development of a Cationic Light-Responsive Polymer for Enhanced Intranasal Gene Delivery

(170) Tailoring Ionizable Lipid Composition for better immune response

(171) Tracking Endosomal Escape of Tunable Polymer Nanoparticles for Inhibition of Inflammatory Pathways

(172) Substituting PEG-Lipid with Amphiphilic Polycarbonates in mRNA-Loaded Lipid Nanoparticles

(173) Synthetic bacterial spores for mRNA targeting and delivery

(174) Preparation of PAMAM Dendrimer-based Nanoclusters for Enhanced Gene Delivery Application

(175) Microfluidic Erythrocyte-Camouflaged Chitosan Nanoparticles for Nucleic Acid Delivery

(176) Preliminary Development of ”Decoy” Oligodeoxynucleotide-LNPs for NF-κB Inhibition

(177) Effect of ionizable lipid source on the quality attributes of siRNA lipid nanoparticle therapeutics

(178) Hybrid vesicles for enhancing intracellular uptake of siRNA

(179) PEGylated siRNA loaded LNPs with enhanced cytosolic release

(180) Real-Time Label-free study of spherical nucleic acids for delivery of antisense TAUoligonucleoutides

(181) Multi-engineered selenium nanoparticles: a smart shuttle for gene therapy of BRAF-mutated melanoma

(182) Ultra-Small Nanomaterial for Co-delivery of Antisense Oligonucleotides to Treat Glioblastoma

(183) Formulation of Mesoscale Lipid Nanoparticles for Targeted Nucleic Acid Delivery to the Kidneys

(184) Novel lipid nanoparticles for pulmonary delivery of circRNA vaccines

(185) An End-to-End High-Throughput Formulation Device Platform for mRNA & LNP Screening

(186) An alternative method to RNA lipid nanoparticle (LNP) production

(187) Layered F-PEI Nanoparticles for Targeted Delivery of TXNDC5 Silencing for Pulmonary Fibrosis

(188) DoE-driven formulation development of multi-miRNA-loaded lipid nanoparticles

(189) Design of improved and safer ionizable lipids for next-generation nanomedicines

(190) Development of polymer-lipid hybrid Hepa-SENS platform technology for the treatment of liver disease

(191) VLP-mediated CRISPR/Cas9 gene editing of islets to inhibit IBMIR in islet transplantation

(192) LafB-mRNA LNP: Advancing S. pneumoniae Vaccination

(193) Optimization of mRNA structure for the enhancement of stability and translational activity

(194) The introduction of Ligand for Enhanced Nuclear Delivery of Antisense Oligonucleotide

(195) Layered Lipid Nanoparticles for Ovarian Tumor-Targeted Gene Delivery

(196) Development of a Targeting Strategy to Enable Selective Photoporation of The Nuclear Envelope

(197) Development of ionizable lipids for gene delivery to the lung using an Ugi four component reaction

(199) Systematic Optimization of Cationic Liposomes for Stable and Efficient mRNA Delivery

(200) LNP-Exosome Hybrid System for Targeted KRASG12D siRNA Delivery in Pancreatic Cancer Therapy

(201) Formulation strategies for stable lipid nanoparticles: insights and implications

(202) Design of PD-L1-Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Immunotherapy

(203) Quaternary amine-based helical polypeptides prime anticancer immunity and facilitate gene delivery

(204) Non-Inflammatory mRNA-LNP Formulation for the Treatment of Type 1 Diabetes

(205) MYELOID TARGETED DISULFIDE LIPID NANOPARTICLE WITH ENHANCED ENDOSOMAL ESCAPE IMPROVES HIV-1 EXCISION

(206) Designing of nanostructured lipid carrier for topical gene silence therapy in chronic wound healing

(207) MMP9 gene silencing by siRNA delivery using hybrid nanoparticles reduced the migration of TNBC cells

(208) Red-light Accelerated Photoactivation of Melittin-mRNA lipid nanoparticles Enhances mRNA Delivery

(209) Advanced Functionalization Strategies for Lipid Nanoparticles: Expanding Delivery Beyond the Liver

(210) Acoustic mRNA delivery via 19F MRI–trackable ultrasound-responsive nanodroplets

(211) APC-Mimetic Lipid Nanoparticles delivering mTOR siRNA for Regulatory T cell Induction

(212) AI-Empowered LNP Discovery for Organ-Targeted RNA Delivery

(213) Surface-Capped Protein Nanoparticles for Non-Viral Gene Delivery

(214) Novel Ether-Ionizable Lipids Complexed into Lipid Nanoparticles Enhance mRNA Delivery Efficiency

(424) Breaking the Endosomal Barrier: Polymer-Enhanced Lipid Nanoparticles for Potent & Safe RNA Delivery

(215) Acid-cleavable Tobramycin cross-linked nanogels for antibiotic delivery to P. aeruginosa biofilms

(216) Enhancing PARP inhibitors efficacy in BRCA1-deficient tumors with radiation-guided nanoparticles

(217) Understanding Depot Formation of Long-Acting Injectable Suspensions: A Physicochemical Perspective

(218) Development of dissolvable microneedles for scalp drug delivery in traction alopecia treatment

(219) Interventions to reduce CAUTIs in primary care settings: A systematic review

(220) Amphotericin B Nanocrystals-in-Nanofibers Films for the Topical Treatment of Cutaneous Leishmaniasis

(221) Electrospun Nanofibers for Dual Probiotic and Antibiotic Delivery Targeting Bacterial Vaginosis

(222) Revolutionizing Abuse Deterrence: Caffeine as a Model for Innovative Formulation Technology

(223) Polypeptide Based Conjugates for Precision Theranostics: Integrating Drug Delivery-Real Time Imaging

(224) Enzyme-activated MRI contrast agent for tumor-specific gadolinium delivery

(225) Advancing Cancer Imaging and Therapy Through Peptide PET Tracers Targeting c-Met

(227) Trehalose Enhanced Cold Atmospheric Plasma-Mediated Cancer Treatment

(228) Programming antitumor gamma delta T cells via a phosphoantigen nanoparticle delivery vehicle

(229) A Cryogel-Based Dendritic Cell Vaccine Enhances Breast Cancer Post-Surgical Immunotherapy

(230) Metabolite induced Treg expansion restores immune homeostasis in multiple autoimmune murine models

(231) Metformin-loaded rod-shaped iron(III) carboxylate biomimetic MOFs for antibacterial immunotherapy

(232) pH-Responsive Peptides for Enhanced Chemotherapy and Anti-tumor Immunity

(233) Development of TAM-targeted nanoparticles for immunotherapy in pancreatic cancer

(234) Sustained Delivery Of Immunoglobulin (IgG) Through Biodegradable Poly(Orthoester) Solid Implant

(235) Mesoporous Silica Based Radionuclide Therapy shows Immunomodulatory Effects & Enhanced Outcome

(236) pH-Sensitive Zinc-Zoledronate Inhalation Therapy for Macrophage Modulation in Lung Cancer

(237) A shared neoantigen melanoma vaccine formulated with a novel biodegradable liquid polymer

(238) Steroid-containing lipid NPs enable mRNA delivery while reducing inflammation in autoimmune disease

(239) LNP-RNA-mediated antigen presentation leverages SARS-CoV-2-specific immunity for cancer treatment

(240) Proteolysis-targeting vaccines (PROTAVs) for robust combination immunotherapy of melanoma

(241) Development of subcutaneous In Situ gelling formulation of anti-PD-L1 peptide for cancer treatment

(242) PEGylated peptide therapeutics for inducing immunosuppressive cells to treat autoimmune diseases

(243) Roles of metabolite polymers regulating immune responses in Rheumatoid Arthritis

(244) Particle shape modulates macrophage phenotype: Insights for cell-mediated drug delivery systems

(245) mRNA formulation development: Looking Beyond the Pandemic

(246) Design of experiments-based development and in vitro evaluation of a triple adjuvanted nanovaccine

(247) Development of mRNA nanoparticles to produce CAR - T cells to treat Diffuse Intrinsic Pontine Glioma

(248) Polymorphism and crystallinity variation of loratadine in polymeric delivery systems

(249) Microfluidic methods for fabrication of W/O/W microspheres using ultra-stable primary emulsion

(251) Twin Screw Extrusion Process Design and Die Modeling for Directly Extruded Implants.

(252) Enlighting the black box: Nanocarrier formation inside microfluidic mixing devices

(253) A manufacturing method of semaglutide-loaded PLGA microspheres using microfluidics

(254) Preparation and evaluation of inhalable nintedanib microparticles using mechanofusion technique

(255) Biocalorimetry to predict bacterial extracellular vesicle production to improve biomanufacturing

(256) Monoliths for a novel selective and high recovering purification process of RNA-LNP pharmaceuticals

(257) Impact of Processing Induced Mesophases on Dexamethasone Release in Polycaprolactone Matrices

(258) Manufacturing Process Design: Scaling up studies for success

(259) Engineering the structural and optical properties of gold nanostars with microfluidics

(260) Reproducible and scalable polymer nanoparticle manufacturing facilitates clinical translation

(261) 3D-Printed Antimicrobial Wound Dressing with Argan-Shell Lignin & EssentialOils for Advanced Healing

(262) Preparation of Rivaroxaban Dry Powder for Inhalation Using a Two-Step Milling Process

(263) Development of a new spray drying method for sustained release of VEGF from marine biopolymers

(264) Revolutionizing Nanovesicle Production for Continuous Manufacturing with In-Line Homogenization

(265) How to make robust a commercial peptide-based lyophilized formulation .

(266) Effect of freezing conditions, cryoprotectant concentrations, and PVP on crystallization

(267) Nano vs. Micro: Impact of Drug Particle Size in Extrusion-based 3D Printing on Tablet Performance

(268) Special challenges for developing sterile biological drug product for intravitreal injection.

(269) Optimizing PAT: Refractometer in Continuous Manufacturing of Lipid-Based Therapeutics

(270) End-To-End Process for Improved Purity, Combined With Innovative Analytics of LNP-Based Therapeutics

(271) DoE-Optimized Process for Residual Ethanol Reduction in Codaewon-S Syrup

(272) Impact of Polymer Concentration on Metformin HCl Tablet Properties and Extended-Release Profiles

(273) Next-Generation Lipid Nanoparticles: Advancing Ionizable and PEG-Free Shielding Lipids

(274) Microstructural and compositional analysis of dexamethasone-loaded poly(lactide-co-glycolide) rods

(275) Pharmacokinetics of a Liposomal Amphotericin B Prepared using Simplified Thin Film Hydration Method

(276) Development of SiRNA-loaded nanobubble formulation with Nova™ Benchtop turbulent mixing system

(226) System of fluorescent nanogels functionalized with glucosamine capable of crossing the BBB

(277) Astrocyte Membrane-Coated Nanoparticles: A Targeted Therapeutic Strategy for Glioblastoma Treatment

(278) Melting the Iceberg – Nanomedicines-driven Matrix Remodeling and Immune Recruitment in PDAC

(279) Creating a novel implant for controlled release to improve radiation sensitivity in prostate cancer

(280) Hyaluronic Acid-Functionalised pH-Responsive Nano-cocktails Targeting Breast Cancer Stem Cells

(281) Lyotropic liquid crystalline mesophases for restoring glutathione peroxidase after oxidative stress

(284) Evaluation of Vaccine Induced Antitumor Response of Cationic Nanoparticles in Colorectal Cancer

(285) Investigating the Cellular Internalization and Endosomal Escape of Polymeric Mesoscale Nanoparticles

(286) In vivo metabolism of cholesterol-containing nanoparticles generates immune modulatory oxysterols

(287) Inhalable TPGS/DPPC Micelles Co-Loaded with Curcumin and Icariin for Targeted Lung Cancer Therapy

(288) Investigating the potential of Dual-drug-loaded Electrospun Nanofibers for Breast Cancer Treatment

(289) Peptide-Guided Nanoparticles for Targeted Temozolomide Delivery in Glioblastoma

(290) Precision-Activated Masked Antibodies Reduce Immune Toxicities in Checkpoint blockade Cancer Therapy

(291) Biological evaluation of lycopene-loaded silica-based nanoparticle for vulvovaginal candidiasis

(292) The Development of Long-acting Teriparatide Formulations to Treat Osteoporosis

(293) Advancing Idiopathic Pulmonary Fibrosis treatment with PROTAC Nanomedicine

(294) A biomimetic redox-responsive hybrid lipid polymer antibiotic-nanocarrier against bacterial sepsis

(295) Inducing Mucosal Immunity in IPV Immunization Using Retinoid Derivative-Encapsulated Nanoparticles

(296) Enhancing mRNA-LNP Efficacy: Investigating the Role of Ionisable and Cationic Lipid Combinations

(297) Urease-powered nanomotors for enhancing bladder cancer chemotherapy

(298) Behavior of Lipid Nanoparticles in Aqueous Formulations

(299) The potential effect of L-carnosine loaded hyalurosomes as a novel anti-aging nano-cosmeceutical gel

(300) Optimization of amiloride-loaded nanoparticles for podocyte injury in glomerular disease.

(301) Drug-loaded cyclodextrin-based polymers to treat pulmonary infections

(302) PLGA Nanobots for therapeutic siRNA delivery: A novel strategy for bladder cancer therapy

(303) Optimizing LNP-RNA Formulations: Key Insights into Size, Zeta Potential, and Stability

(304) Targeted mRNA delivery to metastatic tumors using functionalized nanoparticles

(305) Ratiometric coloaded human serum albumin nanoparticles for effective breast cancer treatment

(306) Polyelectrolyte Complexes as Versatile Vehicles for the Controlled Release of Cefazolin.

(307) API stability improvement using Cyclodextrins: a comparative study of SBEbCD vs HPbCD

(308) Machine Learning-derived Insights in Design of Small Polymeric Nanoparticles for Gene Delivery

(309) A Two-component Two-step Transformable Nanoplatform against Cancers Based on Bioorthogonal Chemistry

(310) Conventional vs PEG-modified PLGA nanoparticles for sodium channel blockade in neuropathic pain

(311) LinTT1 peptide-functionalized Camptothesome enhances tumor delivery, boosting anti-cancer efficacy.

(312) Biodistribution, Pharmacokinetics and Acute Toxicity of Disulfide Crosslinked P(AAm-co-MAA) Nanogels

(313) Tiny Particles, Big Plans: Nanoparticles for Controlling Drug Transfer through the Placental Barrier

(314) Enhanced anti-sarcopenic activity of perindopril erbumine using ultradeformable liposomes

(315) Self-Immolative Polymeric Prodrug for Targeted Cancer Therapy through Disturbing the Redox Balance

(316) Lipidic Nanoparticle for Brain-targeted Treatment in Bacterial Meningitis

(317) Novel Non-Aqueous Emulsification-based Microsphere Platform for Sustained Delivery of Proteins

(318) Phenylboronic acid functionalized poly (lactic-co-glycolic acid) nanoparticles towards lung cancer

(319) Multifunctional nanoparticles to fight hormone-resistant prostate cancer

(320) Engineered Nanobubbles for Inducing Unprogrammed Necrosis in Cancer Immunortherapy

(321) Biodynamers, dynamic protein nanorods, potentiate antibiotics via membrane interactions

(322) pH-dependent Zinc Ion and Photosensitizer Release Nanoparticles for Cancer Targeting Treatment

(323) Electrospinning of nanofibers and the perspectives for dermatological application

(324) pH-sensitive Ionizable Lipid-based Nanoparticles for siRNA delivery to Liver

(325) Enhanced Solubility & Anti-Dilution Properties of Lipophilic Drugs with Solid Micellar Nanoparticles

(326) Nanoparticles-mediated codelivery of cell cycle blockers for the treatment of prostate cancer

(327) Sphingomyelin-derived nanovesicles for the delivery epacadostat enhance melanoma immunotherapy

(328) Engineering Extended-Release Profiles for Biologics via Crosslinking of Poloxamer 407 Hydrogels

(329) Mannosylated Lipid Nanoparticles for Targeted in Vivo mRNA Delivery

(330) Immunoliposomes as a targeted delivery system for enzyme replacement therapy in Fabry disease

(331) 1-Min Nanocrystals: A Fast, Cost-Effective and Efficient Technique to Mill Drugs Using Speed Mixer

(332) Controlled Release of Fluticasone Propionate after Intra-Articular Injection of EP-104IAR in Sheep

(333) Targeted IL-10 mRNA Lipid Nanoparticles Improve Outcomes in Experimental Intracerebral Hemorrhage

(334) Immunomodulatory effects of cholesterol oxidation and their implications in liposomal drug delivery

(335) Endoscopic Delivery of Regorafenib-Curcumin Microparticles to Locally Treat Colorectal Cancer

(336) Targeting Serpinb9 via Gemcitabine-based SiRNA/Drug Nanocarrier to Improve Pancreatic Cancer Therapy

(337) Use of gamma-alumina for acyclovir release

(338) Inhaled lipid nanocarriers for the eradication of pseudomonal biofilms in cystic fibrotic lungs

(339) Lipophilization as a design strategy to tune the release of Tofacitinib from lipid nanoparticles

(340) Thermoresponsive GPNMB-Hydrogels as an Innovative Therapeutic Strategy for Bone Regeneration

(341) Liposome-Encapsulated Bacteriophage Therapy for Drug-Resistant Mycobacterium abscessus

(342) Development of PLGA-Based Nanoparticles for a novel therapeutic peptide in Cardiovascular Diseases

(343) In vitro release testing system development for buprenorphine in situ forming implant

(344) Local Extended-Release Colchicine for Intra-Articular Treatment of Gout Flares

(345) Optimized HPLC Method for TX & FV Estimation in Plasma & Brain: Pharmacokinetics & Biodistribution

(346) Nano-in-micro particles for the pulmonary delivery of remdesivir

(347) An Ultra-long-acting Atovaquone Prodrug Formulation for Malaria Chemoprophylaxis

(348) Effective screening of LNP formulations with centrifugal microfluidics devices

(349) Ginsenoside-Gemcitabine Nanocomplex-based Delivery System for Enhanced Cancer Therapy

(350) Targeting alveolar macrophages with sialic acid-decorated liposomes

(351) An ultra-long-acting prodrug of buprenorphine for opioid dependence

(352) Ionic liquid-based nanoemulsion to improve sorafenib oral absorption & repurposing it in AML therapy

(353) Controlled Release of Gemcitabine with Partially Molecular Imprinted Microspheres for Cancer Therapy

(354) Microneedle enabled dual drug delivery system for vaginal infections using magnetic hyperthermia

(355) Evaluation of Apisolex™ for Parenteral Use: Solubilizing Poorly Soluble Small Molecules and PROTACs

(356) Rational development of donepezil-curcumin intranasal nanotherapies for Alzheimer’s disease

(357) Microfluidics Manufacturing of Liposomal Adjuvants

(358) Marginated Neutrophils Compete for Pulmonary Endothelial-targeted Nanoparticles, part of the RES

(359) Exosome-Liposome Fusion System for Targeted Treatment of MCAO-Induced Brain Injury

(360) Hybrid nanoparticles with TGFβ1 EVs and cartilage-targeting liposomes for osteoarthritis treatment

(361) INFECTION-RESPONSIVE THERANOSTIC SYSTEM FOR PREVENTING & MONITORING SURGICAL & WOUND SITE INFECTIONS

(362) Bioinspired Polymer-Membrane Insulin Crystal Enables Long-Term, Self-Regulated Release

(363) The Extended Potentiated Anticoagulant Effect of Novel Warfarin-α-Tocopherol–Chitosan Nanoparticles

(364) Evaluation of triazine-based lipid nanoparticle (LNP) formulation for mRNA delivery in a mouse model

(365) Hybrid nanoparticles leveraging cell-cell interactions for immunotherapy & metabolic Modulation

(366) Effect of Pegylayion on liposomal adhesion on breast cancer tumor

(367) Insulin-Gold Nanoplatform: Boosting Antibody-Drug Conjugate Efficacy

(368) Refining peptide-functionalized LNPs for enhanced tumor-targeted mRNA delivery

(369) Nanoparticles enhance gemcitabine efficacy by overcoming fibroblast barriers in pancreatic cancer

(370) Lyophilization approach to improve long-term stability of LGA-PEI nanoparticles for drug delivery

(371) Development of a High-Concentration Fulvestrant Depot Formulation with Sustained Release Properties

(372) Surface modification of sustainably-formulated bacterial cellulose nanoparticles for drug delivery

(373) Biodegradable silica-based ultra long-acting tirzepatide formulations for the treatment of obesity

(374) Advancements in Lyophilized Exosomes for Enhanced Stability and Therapeutic Applications

(375) Exploring the Impact of Iron Availability on Antibiotic Resistance in Mycobacterium Species

(376) Design and Screening of Ionizable Lipids for Precision mRNA Delivery to Extrahepatic Organs

(377) Highly Porous Microparticles with TLR7 Agonist-3 Liposomes and siTGF-β LNPs for Pulmonary Fibrosis

(378) Dextran-based T-cell expansion nanoparticles for ex vivo generation of efficacious CAR T cells

(379) Actively targeting colorectal cancer using nanoparticles co-loaded with small molecule inhibitors

(380) Synthesis and non-covalent interaction investigation of metformin-conjugated poly(methyl acrylate)

(381) Towards Understanding LAI Suspensions: Impact of Size Reduction Techniques and Aggregation State

(382) Development of EGFR-Targeted Dual-Loaded Polymeric Nanoparticles for Triple Negative Breast Cancer

(383) Physically Crosslinked Nanocomposite Hydrogels for Sustained Subcutaneous Delivery of Peptides

(384) Development of a solid lipid nanoparticle platform for the delivery of vancomycin

(385) Impact of nanomaterials on the anti-Candida activity of cysteine-modified amidated decoralin

(386) Evaluation of the biocidal activity of Origanum vulgare L. essential oil in nanoemulsion

(387) Polymer-lipid hybrid nanoparticles for sonographic monitoring of subcutaneous fat reduction

(388) Multi-Functional Polymer Nanoparticles for Localized Fat Reduction

(389) Week-long normoglycaemia in diabetic mice and pigs via a dose of glucose-responsive insulin complex

(390) Gas-Driven Fat Reduction with PEG-Based Nanocarriers

(391) Engineered Nanovaccines for STING-Activated Antigen Cross-Presentation in Cancer Immunotherapy

(392) In Vitro Evaluation of Ionizable Lipids in Lipid Nanoparticle (LNP) Formulations.

(393) Budesonide- nanoparticles based inhaled therapy for potential treatment of COPD

(394) Optimizing supramolecular and chemical stability to enhance the design of self-assembling prodrugs

(395) Quantification of Payloads in Lipid Nanoparticles by Scatter-Free UV/Visible Absorption Spectroscopy

(396) Development an injectable in situ formulation of targeted liposomal cisplatin for chemoradiotherapy

(397) Polymeric nanoparticles delivering bevacizumab and avoiding hyperglycolysis in glioblastoma therapy

(399) Paclitaxel-Based Prodrug Hydrogelators

(400) Plasmonic enhanced femtosecond laser anticancer drug delivery using gold-lipid nanoparticles

(401) Design of Supramolecular Hydrogelators for Enhanced Drug Loading and Sustained Therapeutic Release

(402) CD44-Targeted Antibody-Drug Conjugates with Cathepsin B-Cleavable Linker for Ovarian Cancer Therapy

(403) Nicotinamide-loaded Peptoid Nanotubes for Energy Regeneration in Brain Injury

(404) Design, Optimization and Evaluation of Tazarotene Loaded Emulgel Formulation for Treatment of Acne

(405) Antiretroviral Supramolecular Prodrug Hydrogelators as Long-Acting Injectables

(406) Co-delivery of TLR7/8 agonist and Dox using targeted liposome nanocarrier for bladder cancer therapy

(407) AI and Human Based Design of High-Complexity Nano-Therapies for KRAS-Driven Cancer

(408) Development and assessment of a BCS class II drug in the form of solid lipid nanoparticle

(409) Directed discovery of high-loading nanoaggregates enabled by drug-matched oligo-peptide excipients

(410) Investigation of nifedipine and piperine loaded Bio-SNEDDS for the treatment of hypertension

(411) Disruption of the airway mucus barrier enhances nebulized RNA delivery to reverse pulmonary fibrosis

(412) Preparation and characterization of Eudragit S 100 nanoparticles

(413) Antioxidative HABN Targeting Activated Hepatic Stellate Cells for Anti-Hepatic-Fibrosis Therapy

(414) pH-Responsive Doxorubicin Dimeric Nanoassemblies with High Loading, Stability, and Tumor Selectivity

(415) Development of an EZH2 PROTAC-Nanoparticle targeting Breast Cancer Brain Metastases

(416) VCAM-Targeted Delivery of MFSD2A mRNA Mitigates Blood-Brain Barrier Dysfunction in Ischemic Stroke

(417) Developing LNPs for Pediatric Acute Myeloid Leukemia through Two Biological Mechanisms

(418) A 3D Co-Culture Model of Lipid Nanoparticle Uptake in Senescent Pancreatic Cancer

(419) Immuno-Nanoparticles Co-Delivering Rifampicin and Vit D3 for Macrophage-Targeted TB Treatment

(420) Towards Clinical Translation of Autophagy Inhibitor BAQ13 LNP (TR002) for Cancer Therapy

(421) A Novel Long-acting Injectable Formulation Enabling Sustained Release of Dutasteride over 3 months

(423) A novel one month long acting injection (LAI) technology for prolonged release of leuprorelin

(446) Targeted LNPs for Improved In Vivo mRNA Delivery and Immune Responses

(473) Enhancing Therapeutic Efficacy and Immune Response with Bispecific Gold Nanoparticles in Cancer

(510) Comparative ex vivo permeability through healthy and inflamed skin hydrophilic and hydrophobic >500 Da drugs using lipid-based nanovesicles

(425) Biocompatibility assessment of Dexamethasone-Loaded Hydrogel ocular Implants

(426) Developing ciprofloxacin-loaded HEMA contact lenses for sustained release.

(427) Apatinib-loaded polymeric micelles for ophthalmic delivery to the posterior segment

(428) Fenofibrate Eyedrop: A Novel Therapeutic Approach for Mustard Gas-Induced Corneal Injuries

(429) Development of PEG and VE containing block copolymer to form nanomicelles for ocular drug delivery

(430) Inspection of Ocular Drug Delivery Implants

(431) Cationic mucoadhesive Posaconazole NioTherms:A potential approach for management of Fungal Keratitis

(432) Mucoadhesive micelle for anterior segment ocular drug delivery

(433) DECON- a novel platform for Sustained Ocular Delivery of Corticosteroids

(434) Mucoadhesive Polymer-Drug Conjugate and Nanoparticle for Anterior Ophthalmic Drug Delivery

(435) Development of a Polymeric Nanofiber Device for the Prevention of Post-Surgical Secondary Cataracts

(436) Muco-penetrating nanoparticles to sustain drug release for ophthalmic drug delivery

(437) CBD Niosomes as an Innovative Strategy for the Treatment of Retinal Degenerative Diseases

(438) Autologous Serum ocular inserts for treatment of Dry Eye Disease

(439) Loteprednol etabonate-loaded nanoemulsion: anti-inflammatory effect

(440) A dissolvable gel-based in vitro dissolution method for in situ-forming implants

(441) Development of an in situ gelling ocular vehicle: A design of experiments (DOE) approach

(442) In vitro enzymatic degradation of PLGA microparticles

(443) Flavonoid loaded solid lipid nanoparticles in Pluronic gel for combating dry eye disease

(444) Synchronized Codelivery of Dexamethasone and Propranolol for the treatment of Macular Degeneration

(282) Aggregation Behavior of Sodium Caprate: Insights from Coarse-Grained Simulations and SAS Techniques

(445) Dual-Responsive HEMA-Based Hydrogels for Targeted Colonic Delivery of Metronidazole.

(447) Ticagrelor Amorphous Solid Dispersion tablets: formulation with Gelucire® 48/16

(448) Direct Compression of Co-Processed Mannitol-HPMC for Controlled Release Tablets

(449) Triple-strengthened formulation for oral delivery of liraglutide-loaded nanoparticles

(450) Klucel™ Xtend hydroxypropylcellulose (HPC) for Dual Active Diabetic Controlled Release Dosages

(451) Advancing Oral Delivery of Biologic Drugs: Overcome Formulation Challenges with Permeation Enhancers

(452) Designing MELTSOFT: User-Centric Dosage via Hot Melt Extrusion

(453) A190, a new PPARα agonist loaded microemulsion for chemotherapy-induced peripheral neuropathy

(454) Development of pH-responsive Hydrogel in Gastro-Resistant Capsules for Colon Targeted Drug Delivery

(455) Dissolution of Sodium Oxybate ER Drug Product (LUMRYZ) in Different Reconstitution Liquid Vehicles

(456) 3D Printed Bioinspired Mucoadhesive Oral Patch for Long-acting Naltrexone Delivery

(457) Efficient Manufacturing of Delayed Release Minitablets using a Seal and Enteric Coating Approach

(458) Alternative Reconstitution Soft Foods Vehicles for Sodium Oxybate Extended-Release Drug Product

(459) Early Phase Selection of a Controlled Release Amorphous Dispersion Formulation

(460) Harnessing the Power of Human Breast Milk to Boost Intestinal Permeability for Nanoparticles

(461) Identifying optimal process and formulation parameters for the TSWG of acetaminophen using L-HPC

(462) Enteric-coated spherical granules for dual delivery of orlistat & acarbose with diverging properties

(463) Exploring Orodispersible Films Containing the PROTAC ARV-110 in Solvent Casting using PVA

(464) 3D molded carbidopa stoppers for fix dose levodopa gastro retentive tube delivery system

(465) The influence of PEGylated surfactants on the colonic absorption of celecoxib from nano-emulsion

(466) Enabling Oral Delivery of Salmon Calcitonin via SNEDDS: Impact on Protection and Activity

(467) Zero-Order Drug Release from Push-Pull Osmotic Tablets in Varying Dissolution Media

(468) In-Vitro Evaluation of Different Marketed Brands of Metformin Tablets Using Quality Control Tests

(469) Nanoparticle-stabilized Pickering emulsion for oral vaccine delivery

(470) Effect of Hydroxypropyl Cellulose Grade on the Tablet Characteristics in Continuous Granulation

(471) Enhancing pH-responsive drug release in gastrointestinal environment by alginate–CMC/CAP microbeads

(471-A) Impact of HPMC and formulation parameters on the dissolution profiles of modified release tablets

(471-B) Formulation and Process Parameters Optimization in Chewable Tablet.

(283) Liposomal Delivery of Caffeine and Cafestol for Enhanced Skin Absorption

(472) Hydrogel-Forming Microneedles For Vancomycin Delivery To Combat Antimicrobial Resistance

(474) Controlled-Release Surface Coating to Prevent Ventilator-Associated Pneumonia on Endotracheal Tubes

(475) Design and Characterization of Long-acting Subcutaneous Implants Developed Using Hot-Melt Extrusion

(476) Mechanical analysis of pharmaceutical films containing Soluplus for topical delivery of copaiba oil

(477) Characterization of physical properties and design of delivery systems for a chlorin e6 derivative

(478) Formulation and Screening of Ionic Liquid APIs for Transdermal Delivery

(479) Carboxymethyl cellulose dissolving microneedles containing tetracycline for acne vulgaris treatment

(480) In-Situ Forming Implant: Impact of PLGA-Grade and Drug Load on the Drug Release and PLGA Degradation

(481) Microneedle for Rapid and Sustained Delivery of Acetaminophen and Caffeine for Migraine Therapy

(482) Enhancing the storage stability and delivery of extracellular vesicles by using microneedles

(483) SCISSOR for in vitro evaluation and modeling of high concentration mAb formulation SC absorption

(486) Dissolving Microneedle Patch for Localized Photodynamic Therapy in Oral Carcinoma

(487) Redox responsive nanogels for mucosal drug delivery

(488) Development of a Novel Dry Powder Inhaler for Semaglutide: Freeze-Drying Micronization and PK study

(489) Impact of quantitative differences in carbomer on drug release from diclofenac sodium topical gels

(490) In situ forming implants: effect of drug-polymer-solvent interplay on PLGA degradation

(492) Antimicrobial Chitosan-PVA Cryogels with Tailored Nanosilver for Treating Infected Wounds

(493) Lidocaine and Pelubiprofen Eutectic Mixture for Enhanced Endodermal Delivery in Topical Formulations

(494) Developing Long-Term Drug Delivery Systems Using Polyethylene Vinyl Acetate and Loratadine

(495) Enhanced Transdermal Permeation of Diclofenac Sodium using Mango Seed Kernel Starch Nanoparticles

(496) Molecular Dynamics Investigation of Poloxamer/Alginate Hydrogel with Neomycin Sulfate

(497) Development of a transdermal Edaravone patch as a novel parenteral therapeutic system for ALS

(498) Modulation of hair growth by topical drug delivery enhanced by STAR particles

(499) Innovations in Hollow Tube Implants for Targeted Drug Delivery Systems

(500) Unlocking the Potential of Needle-Free Jet Injectors for Intradermal Delivery of Nanoparticles

(501) Amplifying Dual-Drug Microspheres Capacity via Formulation Optimization and Computational Simulation

(503) FINITE ELEMENT MODELLING OF HOLLOW MICRONEEDLE INSERTION AND INTRADERMAL DRUG DELIVERY

(504) An emulsion-based microneedle formulation for transdermal delivery of peptide therapeutics.

(505) Development and Evaluation of a Terbinafine Hydrochloride Film Forming Solution for Athlete’s Foot

(506) Electrosprayed Dry Powder Inhaler (DPI) Formulations of Bevacizumab for the Treatment of NSCLC

(507) Insights from Drug Development: Surveying Challenges & Outcomes for Large-Volume Subcutaneous Drugs

(508) Impact of Gelling Agent on Physicochemical and Q3 Properties of Clobetasol Propionate Gels

(509) Ex vivo platform using viable human skin to study subcutaneous administration of macromolecules